Geneos Wealth Management’s FT Vest U.S. Equity Max Buffer ETF - October OCTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Buy
10,600
+2,000
+23% +$66.6K 0.01% 823
2026
Q1
$280K Hold
8,600
– – 0.01% 860
2025
Q4
$281K Hold
8,600
– – 0.01% 820
2025
Q3
$277K Hold
8,600
– – 0.01% 811
2025
Q2
$270K Buy
8,600
+3,300
+62% +$101K 0.01% 894
2025
Q1
$161K Hold
5,300
– – 0.01% 996
2024
Q4
$162K Buy
+5,300
New +$162K 0.01% 916

Other funds holding OCTM

Geneos Wealth Management's OCTM Position: Q2 2026 in Review

Geneos Wealth Management increased its FT Vest U.S. Equity Max Buffer ETF - October (OCTM) stake by 23% in Q2 2026, buying an estimated $66.6K and bringing the position to 10,600 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #823.

Geneos Wealth Management first reported a position in OCTM in Q4 2024 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold OCTM as of Q2 2026.

  • Geneos Wealth Management held 10,600 shares of FT Vest U.S. Equity Max Buffer ETF - October worth $356K as of Q2 2026.
  • Geneos Wealth Management bought 2,000 FT Vest U.S. Equity Max Buffer ETF - October shares in Q2 2026, an estimated $66.6K.
  • FT Vest U.S. Equity Max Buffer ETF - October made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #823 holding.
  • Geneos Wealth Management first reported a position in FT Vest U.S. Equity Max Buffer ETF - October in Q4 2024 and has held it in 7 quarters since.
  • 38 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - October as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.